News
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second ...
Bristol Myers Squibb (BMS) has announced that its CD19-directed CAR T cell therapy Breyanzi (lisocabtagene maraleucel) has ...
While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...
Merck was a detractor despite "solid" first-quarter results, as it "disappointed the market" with a more subdued outlook for the rest of the year as it trimmed earlier guidance amid a slowdown in ...
PetMed Express CEO and CFO resign, Citizens Financial Group appoints a Barclays exec as CFO and VF’s former finance chief ...
Trump’s Putin meeting crucial for oil prices, Berkshire Hathaway’s mystery solved, the case for rate cuts, and more news to start your day.
The ode to the '70s and '80s San Francisco cultural scene 'Fairyland,' with Emilia Jones, Cody Fern, and Geena Davis, has ...
10h
Zacks.com on MSNAstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs
AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results